67 related articles for article (PubMed ID: 1327524)
21. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions.
Ma PC; Kijima T; Maulik G; Fox EA; Sattler M; Griffin JD; Johnson BE; Salgia R
Cancer Res; 2003 Oct; 63(19):6272-81. PubMed ID: 14559814
[TBL] [Abstract][Full Text] [Related]
22. Lack of class II transactivator causes severe deficiency of HLA-DR expression in small cell lung cancer.
Yazawa T; Kamma H; Fujiwara M; Matsui M; Horiguchi H; Satoh H; Fujimoto M; Yokoyama K; Ogata T
J Pathol; 1999 Jan; 187(2):191-9. PubMed ID: 10365094
[TBL] [Abstract][Full Text] [Related]
23. Differential expression of the LAMB3 and LAMC2 genes between small cell and non-small cell lung carcinomas.
Manda R; Kohno T; Niki T; Yamada T; Takenoshita S; Kuwano H; Yokota J
Biochem Biophys Res Commun; 2000 Aug; 275(2):440-5. PubMed ID: 10964684
[TBL] [Abstract][Full Text] [Related]
24. Production of neuromedin B and neuromedin B gene expression in human lung tumor cell lines.
Cardona C; Rabbitts PH; Spindel ER; Ghatei MA; Bleehen NM; Bloom SR; Reeve JG
Cancer Res; 1991 Oct; 51(19):5205-11. PubMed ID: 1717141
[TBL] [Abstract][Full Text] [Related]
25. Intermediate filament and cross-linked envelope expression in human lung tumor cell lines.
Banks-Schlegel SP; Gazdar AF; Harris CC
Cancer Res; 1985 Mar; 45(3):1187-97. PubMed ID: 2578876
[TBL] [Abstract][Full Text] [Related]
26. Immunocytochemical profile of malignant pleural effusions of small-cell lung cancer.
Tamiolakis D; Papadopoulos N; Cheva A; Lambropoulou M; Kotini A; Mikroulis D; Didilis V; Bitzikas N; Bougioukas G
Minerva Med; 2002 Dec; 93(6):479-83. PubMed ID: 12515971
[TBL] [Abstract][Full Text] [Related]
27. Roles for USF-2 in lung cancer proliferation and bronchial carcinogenesis.
Ocejo-Garcia M; Baokbah TA; Ashurst HL; Cowlishaw D; Soomro I; Coulson JM; Woll PJ
J Pathol; 2005 Jun; 206(2):151-9. PubMed ID: 15856526
[TBL] [Abstract][Full Text] [Related]
28. Characterization of delta opioid receptors in lung cancer using a novel nonpeptidic ligand.
Campa MJ; Schreiber G; Bepler G; Bishop MJ; McNutt RW; Chang KJ; Patz EF
Cancer Res; 1996 Apr; 56(7):1695-701. PubMed ID: 8603422
[TBL] [Abstract][Full Text] [Related]
29. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes.
Broers JL; Raymond Y; Rot MK; Kuijpers H; Wagenaar SS; Ramaekers FC
Am J Pathol; 1993 Jul; 143(1):211-20. PubMed ID: 8391215
[TBL] [Abstract][Full Text] [Related]
30. Role for membrane and secreted insulin-like growth factor-binding protein-2 in the regulation of insulin-like growth factor action in lung tumors.
Reeve JG; Morgan J; Schwander J; Bleehen NM
Cancer Res; 1993 Oct; 53(19):4680-5. PubMed ID: 7691401
[TBL] [Abstract][Full Text] [Related]
31. Loss of expression of death-inducing signaling complex (DISC) components in lung cancer cell lines and the influence of MYC amplification.
Shivapurkar N; Reddy J; Matta H; Sathyanarayana UG; Huang CX; Toyooka S; Minna JD; Chaudhary PM; Gazdar AF
Oncogene; 2002 Dec; 21(55):8510-4. PubMed ID: 12466971
[TBL] [Abstract][Full Text] [Related]
32. A new small cell lung cancer (SCLC)-specific marker discovered through antigenic subtraction of neuroblastoma cells.
Krueger P; Nitz C; Foster R; MacDonald C; Gelber O; Lalehzadeh G; Goodson R; Winter J; Gelber C
Cancer Immunol Immunother; 2003 Jun; 52(6):367-77. PubMed ID: 12669243
[TBL] [Abstract][Full Text] [Related]
33. POU domain transcription factor BRN2 is crucial for expression of ASCL1, ND1 and neuroendocrine marker molecules and cell growth in small cell lung cancer.
Ishii J; Sato H; Sakaeda M; Shishido-Hara Y; Hiramatsu C; Kamma H; Shimoyamada H; Fujiwara M; Endo T; Aoki I; Yazawa T
Pathol Int; 2013 Mar; 63(3):158-68. PubMed ID: 23530560
[TBL] [Abstract][Full Text] [Related]
34. A nonconsensus octamer-recognition sequence (TAATGARAT-motif) identifies a novel DNA binding protein in human Merkel cell carcinoma cell lines.
Thomson JA; Leonard JH; McGregor K; Sturm RA; Parsons PG
Int J Cancer; 1994 Jul; 58(2):285-90. PubMed ID: 8026890
[TBL] [Abstract][Full Text] [Related]
35. Neural lineage-specific homeoprotein BRN2 is directly involved in TTF1 expression in small-cell lung cancer.
Sakaeda M; Sato H; Ishii J; Miyata C; Kamma H; Shishido-Hara Y; Shimoyamada H; Fujiwara M; Endo T; Tanaka R; Kondo H; Goya T; Aoki I; Yazawa T
Lab Invest; 2013 Apr; 93(4):408-21. PubMed ID: 23358112
[TBL] [Abstract][Full Text] [Related]
36. Human small cell lung cancer cells produce brain natriuretic peptide.
Ohsaki Y; Gross AJ; Le PT; Oie H; Johnson BE
Oncology; 1999; 56(2):155-9. PubMed ID: 9949302
[TBL] [Abstract][Full Text] [Related]
37. Identification of somatostatin receptors in human small cell lung carcinoma.
Sagman U; Mullen JB; Kovacs K; Kerbel R; Ginsberg R; Reubi JC
Cancer; 1990 Nov; 66(10):2129-33. PubMed ID: 2171745
[TBL] [Abstract][Full Text] [Related]
38. Re-assessment of acidic glycosphingolipids in small-cell-lung-cancer tissues and cell lines.
Gnewuch C; Jaques G; Havemann K; Wiegandt H
Int J Cancer Suppl; 1994; 8():125-6. PubMed ID: 8194890
[TBL] [Abstract][Full Text] [Related]
39. Neuroendocrine phenotype of small cell lung cancer.
Coulson JM; Ocejo-Garcia M; Woll PJ
Methods Mol Med; 2003; 74():61-73. PubMed ID: 12415686
[TBL] [Abstract][Full Text] [Related]
40. Immunostaining of small-cell carcinoma: mistaken identity?
Schmitt R; Weichert W
Lancet; 2003 Nov; 362(9395):1583; author reply 1583. PubMed ID: 14615122
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
